查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1971252

生物银行市场分析及预测（至2035年）：依类型、产品、服务、技术、应用、材料类型、最终使用者、流程、设备及解决方案划分

Biobanking Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Material Type, End User, Process, Equipment, Solutions
出版日期: | 出版商: Global Insight Services | 英文 316 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生物银行市场预计将从2024年的834亿美元成长到2034年的1,825亿美元，复合年增长率约为8.3%。生物银行市场涵盖用于研发和治疗目的的生物样本的收集、处理、储存和分发。它支持基因组学、个人化医疗和药物研发的进步。该市场的成长动力来自于储存解决方案、资料管理和法规遵循的技术创新。对精准医疗和慢性病研究日益增长的需求正在推动市场成长，而生物样本库在促进获取高品质、符合伦理规范的生物样本方面发挥着至关重要的作用。

生物银行市场正经历显着扩张，主要驱动力来自对个人化医疗日益增长的需求以及基因组学的进步。从细分市场来看，设备领域占据主导，耗材和软体解决方案对于高效的生物银行运作至关重要。诸如储存容器和试剂等耗材是样本保存的必需品，而软体解决方案则增强了资料管理和可追溯性。服务领域的成长率排名第二，样本保存服务对于生物材料的长期储存至关重要。此外，用于再生医学和治疗应用的生物样本库的快速增长也值得关注。生物银行流程的自动化数位化正在加速推进，从而提高营运效率和数据准确性。对冷冻保存技术和生物标记发现的投资预计将进一步推动市场发展。对伦理和监管合规性的日益重视确保了资料的完整性和提供者的保密性。这种不断变化的环境为创新和策略伙伴关係提供了有利机会。

市场区隔
按类型 以人群为基础的生物样本库、以疾病为导向的生物样本库、组织生物样本库、脐带生物样本库、干细胞生物样本库
产品 设备、耗材、软体、分析仪器、储存系统
服务 检体采集、检体处理、检体分析、检体储存、检体运输
科技 自动化生物银行、虚拟生物银行、人工智慧、冷冻保存、基因组学
目的 治疗、研究、临床试验、药物发现、个人化医疗
材料类型 血液製品、人体组织、核酸、细胞株、生物体液
最终用户 学术机构、製药公司、医院、研究机构、诊断中心
过程 收集、保存、分发、品管、资料管理
装置 冷藏库、冷冻库、自动化储存系统、机器人运输系统、离心分离器
解决方案 生物银行软体、资料管理解决方案、样本追踪解决方案、库存管理、合规解决方案

市场概况：

随着主要企业推出创新产品以抓住新机会，生物银行市场正经历市场份额的动态变化。定价策略经过精心製定，旨在平衡竞争定位和附加价值。对个人化和再生医学的关注正在推动新产品的发布，并促进市场发展。北美继续引领市场，其次是欧洲和亚太地区。每个地区都在根据当地需求和技术进步进行调整。由于新参与企业和现有企业的整合，生物银行领域的竞争日益激烈。法规结构，尤其是在北美和欧洲，对于塑造营运标准和影响市场动态至关重要。像赛默飞世尔科技和凯杰这样的公司因其创新方法和对严格法规的遵守而成为行业标竿。该市场的特点是自动化数位化方面的大量投资，提高了样本储存和搜寻的效率。监管环境的持续变化既给市场参与企业带来了挑战，也带来了机会。

主要趋势和驱动因素：

生物银行市场正经历强劲成长，这主要得益于个人化医疗和基因组学研究的进步。关键趋势包括将人工智慧 (AI) 和机器学习技术应用于数据分析和样本管理，从而提升效率和准确性，最终改善研究成果。另一个重要趋势是生物样本库与製药公司之间合作的加强。这种伙伴关係对于药物发现和开发至关重要，因为取得多样化的生物样本能够加速研究方​​法的发展。为确保伦理标准和资料隐私，法规结构也不断完善，从而增强了相关人员之间的信任。此外，慢性病盛行率的上升和人口老化也推动了对生物银行服务的需求。随着医疗保健系统日益重视预防医学，生物样本库在理解疾病机制和开发标靶治疗发挥着至关重要的作用。新兴市场正在进行大量投资，为企业拓展业务和创新创造了机会。能够提供可扩展解决方案并符合监管标准的公司，将在这个充满活力的环境中占据有利地位。

压制与挑战：

生物银行市场面临许多重大限制与挑战。首先，严格的法规结构和伦理考量构成了阻碍。这些法规因司法管辖区而异，增加了合规难度并提高了营运成本。其次，由于生物样本长期储存和维护高成本，生物样本库面临巨大的财务压力。此外，确保长期储存样本的品质和完整性也存在技术挑战。这需要持续投资于最先进的保存技术。另外，缺乏标准化的通讯协定检体和处理流程导致检体品质有差异，进而影响研究结果。此外，资料管理和互通性也面临挑战。生物样本库会产生大量数据，需要复杂的系统进行储存和分析。最后，人们对资料隐私和安全的日益关注意味着资料外洩可能会损害公众信任，并阻碍人们参与生物银行业务。所有这些因素共同阻碍了市场扩张和有效运作。

目录

第一章：执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制因素
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章：细分市场分析

  • 市场规模及预测：依类型
    • 基于人群的生物样本库
    • 疾病导向生物样本库
    • 组织生物库
    • 脐带血生物库
    • 干细胞生物库
  • 市场规模及预测：依产品划分
    • 装置
    • 消耗品
    • 软体
    • 装置
    • 储存系统
  • 市场规模及预测：依服务划分
    • 检体采集
    • 检体处理
    • 检体分析
    • 检体储存
    • 检体运输
  • 市场规模及预测：依技术划分
    • 自动化生物银行
    • 虚拟生物银行
    • 人工智慧
    • 冷冻保存
    • 基因组学
  • 市场规模及预测：依应用领域划分
    • 治疗药物
    • 研究
    • 临床试验
    • 药物发现
    • 个人化医疗
  • 市场规模及预测：依材料类型划分
    • 血液製品
    • 人体组织
    • 核酸
    • 细胞株
    • 生物液体
  • 市场规模及预测：依最终用户划分
    • 学术机构
    • 製药公司
    • 医院
    • 研究所
    • 诊断中心
  • 市场规模及预测：依製程划分
    • 收藏
    • 保持
    • 分配
    • 品管
    • 资料管理
  • 市场规模及预测：依设备类型划分
    • 冷藏库
    • 冷冻库
    • 自动化储存系统
    • 机器人搬运系统
    • 离心机
  • 市场规模及预测：按解决方案划分
    • 生物银行软体
    • 资料管理解决方案
    • 检体追踪解决方案
    • 库存管理
    • 合规解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲国家
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 供需差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 监管概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • BioCision
  • Brooks Life Sciences
  • Biostorage Technologies
  • Cryoport
  • Tecan Group
  • BioKryo
  • Hamilton Company
  • BioLife Solutions
  • DNA Genotek
  • Indivumed
  • Provia Laboratories
  • RUCDR Infinite Biologics
  • Zyagen
  • GenVault
  • Cureline

第九章 关于我们

简介目录
Product Code: GIS33673

Biobanking Market is anticipated to expand from $83.4 billion in 2024 to $182.5 billion by 2034, growing at a CAGR of approximately 8.3%. The Biobanking Market encompasses the collection, processing, storage, and distribution of biological samples for research and therapeutic purposes. It supports advancements in genomics, personalized medicine, and drug development. This market is driven by technological innovations in storage solutions, data management, and regulatory compliance. Increasing demand for precision medicine and chronic disease research is propelling growth, with biobanks playing a pivotal role in facilitating access to high-quality, ethically sourced biospecimens.

The Biobanking Market is experiencing significant expansion, primarily driven by heightened demand for personalized medicine and advancements in genomics. Among the segments, the equipment sector is leading, with consumables and software solutions being pivotal for efficient biobanking operations. Consumables such as storage containers and reagents are essential for sample preservation, while software solutions enhance data management and traceability. The service segment is the second highest performing, with sample storage services being crucial for long-term biological material preservation. Additionally, the rapid growth of biobanks focused on regenerative medicine and therapeutic applications is noteworthy. Automation and digitalization of biobanking processes are gaining momentum, improving operational efficiency and data accuracy. Investments in cryopreservation and biomarker discovery are expected to further propel the market. The emphasis on ethical and regulatory compliance is increasing, ensuring data integrity and donor confidentiality. This evolving landscape presents lucrative opportunities for innovation and strategic partnerships.

Market Segmentation
TypePopulation-based Biobanks, Disease-oriented Biobanks, Tissue Biobanks, Umbilical Cord Biobanks, Stem Cell Biobanks
ProductEquipment, Consumables, Software, Instruments, Storage Systems
ServicesSample Collection, Sample Processing, Sample Analysis, Sample Storage, Sample Transportation
TechnologyAutomated Biobanking, Virtual Biobanking, Artificial Intelligence, Cryopreservation, Genomics
ApplicationTherapeutics, Research, Clinical Trials, Drug Discovery, Personalized Medicine
Material TypeBlood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids
End UserAcademic Institutions, Pharmaceutical Companies, Hospitals, Research Laboratories, Diagnostic Centers
ProcessCollection, Preservation, Distribution, Quality Control, Data Management
EquipmentRefrigerators, Freezers, Automated Storage Systems, Robotic Handling Systems, Centrifuges
SolutionsBiobanking Software, Data Management Solutions, Sample Tracking Solutions, Inventory Management, Compliance Solutions

Market Snapshot:

The biobanking market is witnessing a dynamic shift in market share, with leading companies launching innovative products to capture emerging opportunities. Pricing strategies are being meticulously crafted, balancing between competitive positioning and value addition. The focus on personalized medicine and regenerative therapies has catalyzed new product launches, driving the market's evolution. North America remains at the forefront, with Europe and Asia-Pacific trailing closely, each adapting to regional demands and technological advancements. Competition within the biobanking sector is intensifying, driven by the entrance of new players and the consolidation of existing ones. Regulatory frameworks, particularly in North America and Europe, are crucial in shaping operational standards, impacting market dynamics. Companies like Thermo Fisher Scientific and Qiagen are benchmarked for their innovative approaches and compliance with stringent regulations. The market is characterized by significant investments in automation and digitalization, enhancing sample storage and retrieval efficiencies. The continuous evolution of regulatory landscapes offers both challenges and opportunities for market participants.

Geographical Overview:

The biobanking market is witnessing notable growth across various regions, each characterized by unique dynamics. North America leads the market, driven by substantial investments in life sciences and personalized medicine. The region's robust healthcare infrastructure and research initiatives further bolster its position. Europe follows, with a strong focus on biobanking for regenerative medicine and rare disease research. The region's regulatory framework supports innovation and collaboration. In Asia Pacific, the market is expanding rapidly, fueled by advancements in biotechnology and government support for healthcare research. Countries like China and India are emerging as key players, investing heavily in biobanking infrastructure. Latin America and the Middle East & Africa are also exhibiting growth potential. In Latin America, increasing research activities and collaborations are driving demand. Meanwhile, the Middle East & Africa are recognizing biobanking's role in enhancing healthcare outcomes and fostering economic development through innovation.

Key Trends and Drivers:

The biobanking market is experiencing robust growth, driven by advancements in personalized medicine and genomic research. Key trends include the integration of artificial intelligence and machine learning to enhance data analysis and sample management. These technologies facilitate more efficient and accurate processing, leading to improved research outcomes. Another significant trend is the increasing collaboration between biobanks and pharmaceutical companies. This partnership is crucial for drug discovery and development, as access to diverse biological samples accelerates the research process. Regulatory frameworks are also evolving to ensure ethical standards and data privacy, fostering trust among stakeholders. Furthermore, the rise in chronic diseases and the aging population are driving demand for biobanking services. As healthcare systems focus on preventive care, biobanks play a pivotal role in understanding disease mechanisms and developing targeted therapies. Emerging markets are witnessing substantial investments, presenting opportunities for expansion and innovation. Companies that can offer scalable solutions and adhere to regulatory standards are well-positioned to thrive in this dynamic landscape.

Restraints and Challenges:

The biobanking market is encountering several significant restraints and challenges. Firstly, stringent regulatory frameworks and ethical considerations impose barriers. These regulations vary across jurisdictions, complicating compliance and increasing operational costs. Secondly, biobanks face substantial financial constraints due to the high costs associated with long-term storage and maintenance of biological samples. Moreover, there is a technological challenge in ensuring the quality and integrity of stored samples over extended periods. This requires continuous investment in state-of-the-art preservation technologies. Additionally, the lack of standardized protocols for sample collection and processing leads to variability in sample quality, impacting research outcomes. Furthermore, there is a challenge in data management and interoperability. Biobanks generate vast amounts of data that require sophisticated systems for storage and analysis. Lastly, there is a growing concern about data privacy and security, as breaches can undermine public trust and hinder participation in biobanking initiatives. These factors collectively impede the market's expansion and effectiveness.

Key Players:

BioCision, Brooks Life Sciences, Biostorage Technologies, Cryoport, Tecan Group, BioKryo, Hamilton Company, BioLife Solutions, DNA Genotek, Indivumed, Provia Laboratories, RUCDR Infinite Biologics, Zyagen, GenVault, Cureline

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Equipment
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Population-based Biobanks
    • 4.1.2 Disease-oriented Biobanks
    • 4.1.3 Tissue Biobanks
    • 4.1.4 Umbilical Cord Biobanks
    • 4.1.5 Stem Cell Biobanks
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Equipment
    • 4.2.2 Consumables
    • 4.2.3 Software
    • 4.2.4 Instruments
    • 4.2.5 Storage Systems
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Sample Collection
    • 4.3.2 Sample Processing
    • 4.3.3 Sample Analysis
    • 4.3.4 Sample Storage
    • 4.3.5 Sample Transportation
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Automated Biobanking
    • 4.4.2 Virtual Biobanking
    • 4.4.3 Artificial Intelligence
    • 4.4.4 Cryopreservation
    • 4.4.5 Genomics
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Therapeutics
    • 4.5.2 Research
    • 4.5.3 Clinical Trials
    • 4.5.4 Drug Discovery
    • 4.5.5 Personalized Medicine
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Blood Products
    • 4.6.2 Human Tissues
    • 4.6.3 Nucleic Acids
    • 4.6.4 Cell Lines
    • 4.6.5 Biological Fluids
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Academic Institutions
    • 4.7.2 Pharmaceutical Companies
    • 4.7.3 Hospitals
    • 4.7.4 Research Laboratories
    • 4.7.5 Diagnostic Centers
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Collection
    • 4.8.2 Preservation
    • 4.8.3 Distribution
    • 4.8.4 Quality Control
    • 4.8.5 Data Management
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Refrigerators
    • 4.9.2 Freezers
    • 4.9.3 Automated Storage Systems
    • 4.9.4 Robotic Handling Systems
    • 4.9.5 Centrifuges
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Biobanking Software
    • 4.10.2 Data Management Solutions
    • 4.10.3 Sample Tracking Solutions
    • 4.10.4 Inventory Management
    • 4.10.5 Compliance Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Equipment
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Equipment
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Equipment
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Equipment
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Equipment
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Equipment
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Equipment
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Equipment
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Equipment
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Equipment
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Equipment
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Equipment
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Equipment
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Equipment
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Equipment
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Equipment
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Equipment
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Equipment
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Equipment
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Equipment
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Equipment
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Equipment
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Equipment
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Equipment
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 BioCision
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Brooks Life Sciences
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Biostorage Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Cryoport
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Tecan Group
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 BioKryo
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Hamilton Company
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 BioLife Solutions
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 DNA Genotek
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Indivumed
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Provia Laboratories
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 RUCDR Infinite Biologics
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Zyagen
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 GenVault
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Cureline
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us